[go: up one dir, main page]

IL118381A0 - Solutions containing erythromycylamine and their use - Google Patents

Solutions containing erythromycylamine and their use

Info

Publication number
IL118381A0
IL118381A0 IL11838196A IL11838196A IL118381A0 IL 118381 A0 IL118381 A0 IL 118381A0 IL 11838196 A IL11838196 A IL 11838196A IL 11838196 A IL11838196 A IL 11838196A IL 118381 A0 IL118381 A0 IL 118381A0
Authority
IL
Israel
Prior art keywords
erythromycylamine
solutions containing
solutions
containing erythromycylamine
Prior art date
Application number
IL11838196A
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of IL118381A0 publication Critical patent/IL118381A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL11838196A 1995-05-23 1996-05-22 Solutions containing erythromycylamine and their use IL118381A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19518917A DE19518917A1 (en) 1995-05-23 1995-05-23 Stable, concentrated, locally tolerated erythromycylamine solutions

Publications (1)

Publication Number Publication Date
IL118381A0 true IL118381A0 (en) 1996-09-12

Family

ID=7762671

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11838196A IL118381A0 (en) 1995-05-23 1996-05-22 Solutions containing erythromycylamine and their use

Country Status (6)

Country Link
AR (1) AR002069A1 (en)
AU (1) AU5898296A (en)
DE (1) DE19518917A1 (en)
IL (1) IL118381A0 (en)
WO (1) WO1996037190A1 (en)
ZA (1) ZA964082B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723447A (en) * 1996-07-02 1998-03-03 Rhone Merieux, Inc. Water miscible erythromycin solutions
NZ523693A (en) * 2000-07-10 2004-08-27 Chiron Corp Macrolide formulations for inhalation and methods of treatment of endobronchial infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA695765B (en) * 1968-08-29 1971-03-31 Lilly Co Eli Erythromycylamine and process for preparing same
ZA71763B (en) * 1970-04-13 1972-03-29 Lilly Industries Ltd Erythromycylamines via hydrazones
ZA87591B (en) * 1986-02-03 1988-09-28 Lilly Co Eli Novel derivatives of eryhromycylamine
US5110800A (en) * 1986-02-18 1992-05-05 Eli Lilly And Company Derivatives of erythromycylamine
DE4410637C1 (en) * 1994-03-26 1995-09-21 Boehringer Ingelheim Vetmed Injectable solutions of dirithromycin

Also Published As

Publication number Publication date
ZA964082B (en) 1996-11-22
AR002069A1 (en) 1998-01-07
DE19518917A1 (en) 1996-11-28
AU5898296A (en) 1996-12-11
WO1996037190A1 (en) 1996-11-28

Similar Documents

Publication Publication Date Title
GB2298422B (en) Compounds and their use
IL122428A0 (en) Minizymes and minribozymes and uses thereof
HU9602104D0 (en) Novel medicines and their use
ZA94344B (en) Solutions and their preparation
IL118442A0 (en) Triazolymethyl-cyclopentanols their preparation and use
GB9500856D0 (en) Composition and use
IL118441A0 (en) Triazolymethyl-oxiranes their preparation and use
EP0836617A4 (en) Parevins and tachytegrins
ZA964862B (en) Optimized minizymes and miniribozymes and uses thereof
IL118444A0 (en) Mercapto-triazolyl-silanes their preparation and use
IL122686A0 (en) Benzylhydroxylamines their preparation and use
IL118381A0 (en) Solutions containing erythromycylamine and their use
GB9526407D0 (en) Substances and their uses
GB9501907D0 (en) Allatostatins and their use
GB9525234D0 (en) Process compound and use
SG44332A1 (en) Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas
GB9512703D0 (en) Composition and use
HUT76036A (en) Mono-noble metal-dithio-late, agents containing those and their use
GB9507541D0 (en) Substances and their uses
GB9510392D0 (en) Substances and their uses
GB9504258D0 (en) Substances and their uses
GB9501010D0 (en) Substances and their uses
GB9512325D0 (en) Substances and their uses
GB9515484D0 (en) Substances and their uses
GB9515482D0 (en) Substances and their uses